Bioteque (ROCO:4107) Total Equity: NT$3,607 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4107 Bioteque Corp ROCO:4107
85 GF Score
Price NT$118.50
GF Value NT$129.33
Valuation Fairly Valued
View Full Analysis

What is Bioteque Total Equity?

Bioteque ROCO:4107 -1.25% 85 Total Equity is NT$3,607 Mil as of Dec. 2025. GuruFocus rates ROCO:4107 with a GF Score™ of 85/100 and a GF Value™ of NT$129.33 (Fairly Valued).

Bioteque's total equity for the quarter that ended in Dec. 2025 was NT$3,607 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Bioteque Total Equity Historical Data

* Premium members only.

The historical data trend for Bioteque's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioteque Total Equity Chart

Bioteque Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,803.18 3,031.99 3,190.13 3,440.97 3,607.17

Bioteque Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,440.97 3,236.91 3,290.07 3,435.38 3,607.17
ROCO:4107
85GF Score
Bioteque Corp ROCO:4107
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioteque Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Bioteque's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=4659.999-1052.827
=3,607

Bioteque's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=4659.999-1052.827
=3,607

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of NT$3,607 Mil mean?
Bioteque (ROCO:4107) has a Total Equity of NT$3,607 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Bioteque and its competitors.
Is Bioteque's Total Equity too high?
Bioteque's current Total Equity is NT$3,607 Mil. Overall, Bioteque has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bioteque's Total Equity compare to ISRG and BDX?
Bioteque's Total Equity of NT$3,607 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Bioteque and its competitors. Bioteque's current Total Equity is NT$3,607 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioteque stock overvalued right now?
Based on GuruFocus' analysis, Bioteque (ROCO:4107) is currently considered Fairly Valued. The stock's GF Value™ is NT$129.33, compared to a current price of NT$118.50 — trading 8.4% below its estimated fair value. The current Total Equity is NT$3,607 Mil. Bioteque's overall GF Score™ is 85/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Bioteque (ROCO:4107), the current Total Equity is NT$3,607 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioteque (ROCO:4107) Overvalued in 2026?

Based on GuruFocus' analysis, Bioteque stock appears to be undervalued. The current stock price of NT$118.50 is trading 8.4% below its estimated GF Value™ of NT$129.33. GuruFocus considers Bioteque to be Fairly Valued.

Key valuation signals for ROCO:4107:

  • Total Equity: NT$3,607 Mil
  • GF Value™: NT$129.33 vs. price of NT$118.50 (8.4% below fair value)
  • GF Score™: 85/100

No single metric tells the full story. See the ROCO:4107 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioteque Business Description

Address Chang-An E. Road, 5th Floor-6, No.23, Section 1, Taipei, TWN, 104
Bioteque Corp is engaged in manufacturing, trading, and selling medical equipment and instruments. The company operates in different segments such as Manufacturing medical disposables for hemodialysis use, and selling them to dealers and retailers; Manufacturing and selling catheters for healthcare and medical PVC IV bags to medical organizations; Manufacturing and selling medical key components and inner catheters to the medical organization; and Other segment. Geographically, the company generates a majority of its revenue from Asia and the rest from North America, South America, and other regions.
85GF Score

Get the complete analysis for ROCO:4107

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$118.50
Price
NT$129.33
GF Value